Lyme disease vaccines

Details Lyme disease vaccines Lyme disease vaccines

2005-06-07

2005-06-07

Horlick, Kenneth R. (Department: 1637)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091200, C536S022100, C536S024300

Reexamination Certificate

active

06902893

ABSTRACT:
The present invention relates to novel vaccines for the prevention or attenuation of Lyme disease. The invention further relates to isolated nucleic acid molecules encoding antigenic polypeptides ofBorrelia burgdorferi. Antigenic polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the sane. The invention additionally relates to diagnostic methods for detecting,Borreliagene expression.

REFERENCES:
patent: 5466577 (1995-11-01), Weisburg
patent: 5582990 (1996-12-01), Bergstrom et al.
patent: WO 95/04145 (1995-02-01), None
Marconi et al, Journal of Bacteriology, 1996, vol. 178(19), p. 5615-5626.
Search report accession No. U80956 L78245.

Affiliated with

Also associated with

Rating

Lyme disease vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lyme disease vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lyme disease vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3476983